연구

연구업적

최근 5년 연구업적 현황
연도 2024년 2023년 2022년 2021년 2020년
SCI 논문
발표편수
책임 179편 173편 163편 184편 135편
공동 147편 120편 115편 136편 168편
합계 326편 293편 278편 320편 303편
1607. Unique features of young age breast cancer and its management
Lee HB, Han W
J Breast Cancer. 2014 Dec;17(4):301-7. Link
1606. Nomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy
Kim MK,?Han W,?Moon HG,?Ahn SK,?Kim J,?Lee JW,?Kim JY,?Kim T,?Lee KH,?Kim TY,?Han SW,?Im SA,?Kim TY,?Park IA,?Noh DY
Cancer Res Treat.?2014 Sep 4. [Epub ahead of print] Link
1605. Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)
Kim J, Lim W, Kim EK, Kim MK, Paik NS, Jeong SS, Yoon JH, Park CH, Ahn SH, Kim LS, Han S, Nam SJ, Kang HS, Kim SI, Yoo YB, Jeong J, Kim TH, Kang T, Kim SW, Jung Y, Lee JE, Kim KS, Yu JH, Chae BJ, Jung SY, Kang E, Choi SY, Moon HG, Noh DY, Han W
BMC Cancer. 2014 Mar 10;14:170 Link
1604. KRAS Mutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX
Lee DW, Kim KJ, Han SW, Lee HJ, Rhee YY, Bae JM, Cho NY, Lee KH, Kim TY, Oh DY, Im SA, Bang YJ, Jeong SY, Park KJ, Park JG, Kang GH, Kim TY.
Ann Surg Oncol. 2014 Jun 3 Epub Link
1603. RNA editing in RHOQ promotes invasion potential in colorectal cancer.
Han SW, Kim HP, Shin JY, Jeong EG, Lee WC, Kim KY, Park SY, Lee DW, Won JK, Jeong SY, Park KJ, Park JG, Kang GH, Seo JS, Kim JI, Kim TY.
J Exp Med. 2014;211(4):613-21 Link
1602. A convenient and less invasive technique of labial minor salivary gland biopsy using a minimal incision with a needle tip.
Lee WY, Choi YS, Ahn SH, Hah JH
Clin Exp Otorhinolaryngol. 2014 Sep;7(3):222-5 Link
1601. Neck computed tomography in pediatric neck mass as initial evaluation in ED: is it malpractice?
Lee DY, Seok J, Kim YJ, Kim MS, Sung MW, Hah JH
Am J Emerg Med. 2014 Oct;32(10):1237-40. Link
1600. Endoplasmic reticulum stress response as a possible mechanism of cyclooxygenase-2-independent anticancer effect of celecoxib.
Cha W, Park SW, Kwon TK, Hah JH, Sung MW.
Anticancer Res. 2014 Apr;34(4):1731-5. Link
1599. HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells.
Hah JH, Zhao M, Pickering CR, Frederick MJ, Andrews GA, Jasser SA, Fooshee DR, Milas ZL, Galer C, Sano D, William WN Jr, Kim E, Heymach J, Byers LA, Papadimitrakopoulou V, Myers JN.
Head Neck. 2014 Nov;36(11):1547-54. Link
1598. The value of SPECT/CT in localizing the pain site and prediction of treatment response in patients with chronic low back pain
Lee I, Budiawan H, Moon JY, Cheon GJ, Kim YC, Paeng JC, Kang KW, Chung JK, Lee DS
J Korean Med Sci 2014; 29:1711-1716 Link